Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 22:7:e56684.
doi: 10.2196/56684.

A Survey of Demographics and Treatments in Melanoma Case Reports: Retrospective Bibliometric Analysis

Ross O'Hagan  1   2 , Jessie Ngandjui  2 , Benjamin Ungar  1 , Jonathan Ungar  1 , Nicholas Gulati  1
Affiliations

A Survey of Demographics and Treatments in Melanoma Case Reports: Retrospective Bibliometric Analysis

Ross O'Hagan et al. JMIR Dermatol. .

Abstract

Melanoma case reports show variations in treatment by age and sex.

Keywords: case reports; chemotherapy; immunotherapy; melanoma; radiation therapy; surgery.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: BU is an employee of Mount Sinai and has received research funds (grants paid to the institution) from Incyte, Rapt Therapeutics, and Pfizer. He is also a consultant for Arcutis Biotherapeutics, Bristol Myers Squibb, Castle Biosciences, Fresenius Kabi, Pfizer, Sanofi, and UCB. JU is an employee of Mount Sinai and is a consultant for AbbVie, Bristol Myers Squibb, Castle Biosciences, Dermavant, Janssen, Menlo Therapeutics, Mitsubishi Tanabe Pharma America, and UCB. RO, JN, and NG declare no relevant conflicts of interest.

Figures

Figure 1
Figure 1
Age histogram of patients with melanoma.
See this image and copyright information in PMC

References

    1. O'Hagan R, Caldas SA, Brunner PM, Ungar B. A survey of patient demographics in inflammatory skin disease case reports. JMIR Dermatol. 2023 Sep 25;6:e49070. doi: 10.2196/49070. https://derma.jmir.org/2023//e49070/ v6i1e49070 - DOI - PMC - PubMed
    1. Cortez JL, Vasquez J, Wei ML. The impact of demographics, socioeconomics, and health care access on melanoma outcomes. J Am Acad Dermatol. 2021 Jun;84(6):1677–1683. doi: 10.1016/j.jaad.2020.07.125.S0190-9622(20)32405-1 - DOI - PubMed
    1. Schwartz MR, Luo L, Berwick M. Sex differences in melanoma. Curr Epidemiol Rep. 2019 Jun 31;6(2):112–118. doi: 10.1007/s40471-019-00192-7. https://europepmc.org/abstract/MED/32855900 - DOI - PMC - PubMed
    1. Zhao Z, Jin Q, Chen F, Peng T, Yu S. PMC-Patients: a large-scale dataset of patient summaries and relations for benchmarking retrieval-based clinical decision support systems. doi: 10.48550/arXiv.2202.13876. arXiv. Preprint posted online on February 28, 2022. - DOI
    1. Jain V, Hwang W, Venigalla S, Nead KT, Lukens JN, Mitchell TC, Shabason JE. Association of age with efficacy of immunotherapy in metastatic melanoma. Oncologist. 2020 Feb;25(2):e381–e385. doi: 10.1634/theoncologist.2019-0377. https://europepmc.org/abstract/MED/32043765 - DOI - PMC - PubMed

Publication types